Fortis Therapeutics
PrivateLast Round
Series A
Extension
Mar 29, 2021
Total Funding Raised
$58M
Company Overview
Fortis Therapeutics operates in Healthcare & Life Sciences and is based in La Jolla, California. Its latest recorded funding round was a Series A Extension round in March 2021.
Fortis Therapeutics is a biotechnology company that develops antibody-drug conjugate therapies targeting CD46 for the treatment of multiple myeloma and late-stage prostate cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Fortis Therapeutics Comparables
Compare Fortis Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MBrace Therapeutics | 82% | |
| Kyntra Bio, Inc. | 81% | |
| TORL BioTherapeutics | 78% |
For institutional investors. Book with your work email.
Fortis Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Mar 29, 2021 | ||||
| Series A | Sep 27, 2016 |
For institutional investors. Book with your work email.
Fortis Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Osage University Partners | Series A, Series A Extension |
| Avalon Ventures | Series A, Series A Extension |
| Lilly Asia Ventures | Series A, Series A Extension |
| Lilly Asia Ventures | Series A, Series A Extension |
| Avalon BioVentures | Series A, Series A Extension |
| Vivo Capital | Series A, Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 29, 2021
$40M round led by Avalon Ventures.
- Sep 27, 2016
$18M round led by Avalon BioVentures and Avalon Ventures.
For institutional investors. Book with your work email.
Fortis Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Fortis Therapeutics's valuation, stock price, and market status.
Is Fortis Therapeutics a public or private company?
Fortis Therapeutics is a private company.
What is the current stock price of Fortis Therapeutics?
Fortis Therapeutics is a private company, so its shares have no public market price. Caplight tracks Fortis Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Fortis Therapeutics worth (valuation)?
Valuation information for Fortis Therapeutics is not publicly available.
Can I buy Fortis Therapeutics stock?
Fortis Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Fortis Therapeutics's last funding round?
Fortis Therapeutics's most recent funding round was Series A Extension on March 29, 2021.
Who are the main investors in Fortis Therapeutics?
Key investors in Fortis Therapeutics include Avalon Ventures, Avalon BioVentures.
Will Fortis Therapeutics IPO soon?
No public IPO plans have been announced for Fortis Therapeutics.
How can I track Fortis Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Fortis Therapeutics's shares on secondary markets.